REGISTER
MedJ at ESMO 2025 with Dr. Myung-Ju Ahn
Emerging findings make MedJ at ESMO 2025 with Dr. Myung-Ju Ahn more relevant than before. The article traces the core results involving ESMO, MD, medj and explains their implications for routine care and future research.

Myung-Ju Ahn, MD, Samsung Medical Center, Korea

ESMO Live Interpretation of Bispecific Antibody Synergistic Mechanisms Provides Breakthrough Strategies to Overcome Drug Resistance, Pioneering New Directions in Personalized Lung Cancer Treatment.

0
0
Loading